Back to Stocks
Rank #1192GRFS
Grifols, S.A.
$9.44
-2.78% (Daily)
Market Cap
$7.79B
Revenue
$7.52B
Rank by MCap
#1192
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Mr. Víctor Grifols Deu
Headquarters
Barcelona
Employees
23,800
About Grifols, S.A.
Grifols, S.A. operates as a plasma therapeutic company in Spain, the United States, Canada, and internationally. The company provides immunoglobulin to treat immunodeficiencies; albumin used to restore circulatory volume and protein loss in pathophysiological conditions, such as liver cirrhosis, cardiocirculatory failure, trauma, and severe burns; alpha-1 proteinase inhibitor, a plasma protein, used to treat a genetic disease known as alpha-1; factor VIII/von Willebrand factor and factor IX, ...
Grifols, S.A. Price Chart
Loading chart…